Medicinal Chemists are specialized scientists focused on the design, synthesis, and development of chemical compounds that can become pharmaceutical drugs. Their work bridges the gap between chemistry and pharmacology, applying principles of organic chemistry to develop molecules that interact with biological systems in therapeutic ways. Medicinal chemists are responsible for optimizing the chemical properties of compounds to improve their effectiveness, stability, and bioavailability. Their goal is to identify molecules that can target specific biological pathways or diseases while minimizing side effects. Through techniques like structure-activity relationship (SAR) analysis, they refine drug candidates to meet the necessary criteria for preclinical and clinical testing. Medicinal chemists are also crucial in addressing emerging healthcare challenges, such as the development of drugs for antibiotic-resistant infections.
Medicinal chemists work closely with pharmacologists, toxicologists, and formulation scientists to ensure the drug candidates are suitable for development. They are involved in every step of the drug discovery process, from the initial hit identification through to lead optimization and scale-up for clinical trials. These chemists also tackle challenges like drug resistance and metabolic degradation, working to create more potent, long-lasting therapies. With the rise of personalized medicine, medicinal chemists are increasingly focused on developing drugs tailored to individual genetic profiles. Their expertise remains essential in driving forward the discovery and development of new, life-saving therapies.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico